EP3061447A1 — Solvent system for enhancing the solubility of pharmaceutical agents
Assigned to Patheon Softgels Inc · Expires 2016-08-31 · 10y expired
What this patent protects
The invention is directed to a pharmaceutical composition comprising: (a) naproxen sodium; (b) lactic acid in an amount of from 0.2 to 1.0 mole equivalents per mole of the naproxen sodium; (c) polyethylene glycol; and (d) a solubilizer selected from glycerin, polyvinylpyrroli…
USPTO Abstract
The invention is directed to a pharmaceutical composition comprising: (a) naproxen sodium; (b) lactic acid in an amount of from 0.2 to 1.0 mole equivalents per mole of the naproxen sodium; (c) polyethylene glycol; and (d) a solubilizer selected from glycerin, polyvinylpyrrolidone, propylene glycol, or combinations thereof. The compositions of the invention may be encapsulated in a softgel capsule.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.